Indo Amines Ltd (INDOAMIN)
๐ฏ Key Takeaways
- Indo Amines Ltd is in a stable growth phase, leveraging its niche position in specialty amines to deliver consistent profitability amid modest top-line expansion. The company maintains strong returns on capital and low leverage, but recent revenue trends show signs of softening, with quarterly growth flattening and margins under slight pressure.
- Revenue grew 18% QoQ to โน375 in Q1FY27.
- โ ๏ธ Margin pressure persists despite revenue growth, with OPM flattening at 12.4% in Q2 FY27, raising concerns about cost control in a competitive chemica
- Market Cap
- โน1,060
- P/E Ratio
- 13.2
- P/B Ratio
- 2.70
- ROE
- 20.7%
- ROCE
- 19.3%
- Debt/Equity
- 0.79
- Div Yield
- 0.34%
- Promoter
- 58.4%
๐ The Story
Indo Amines Ltd is in a stable growth phase, leveraging its niche position in specialty amines to deliver consistent profitability amid modest top-line expansion. The company maintains strong returns on capital and low leverage, but recent revenue trends show signs of softening, with quarterly growth flattening and margins under slight pressure. Management continues to focus on operational efficiency and governance compliance, with leadership continuity reinforced through recent shareholder approvals.
๐ฐ What's Happening
In Q1 FY27, the board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, marking the first full quarter under the new financial year. Shareholders approved all four special resolutions via remote e-voting, including the re-appointment of Mrs. Bharati Palkar as Whole-Time Director for three years and increased remuneration for key managerial personnel, reflecting confidence in management continuity. An Additional Independent Director, Rahul Chitnis, was appointed pending shareholder approval, further strengthening governance oversight. These governance actions underscore a disciplined approach to board composition and succession planning, with no major strategic shifts announced.
Source: Stock Announcements
๐ Quarterly Results (โน Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 288 | 277 | 277 | 318 | 375 |
| Operating Profit | 26 | 27 | 20 | 28 | 46 |
| OPM % | 9.1% | 9.7% | 7.2% | 8.9% | 12.4% |
| Net Profit | 29 | 18 | 12 | 21 | 31 |
| EPS | โน3.94 | โน2.50 | โน1.62 | โน2.73 | โน4.19 |
Revenue has shown sequential improvement, rising from โน277 crore in Q4 FY26 to โน318 crore in Q1 FY27 and โน375 crore in Q2 FY27, indicating modest but steady growth. However, operating margins have plateaued around 12%, with slight compression observed in the latest quarter despite higher volumes, suggesting input cost pressures or pricing constraints. Net profit and EPS have risen in tandem with revenue, supporting the companyโs profitability trajectory, though the pace of growth has slowed compared to earlier quarters.
๐ฎ Management Outlook & What's Next
Management has not provided explicit forward guidance in the latest filings beyond confirming the approval of Q1 FY27 results and ongoing compliance with regulatory norms. There is no public commentary on future revenue targets, margin expectations, or capital allocation strategy in the recent disclosures. The focus remains on operational execution and governance rather than expansionary guidance.
Extracted from official company announcements. Not StockFin.ai's opinion.
๐ฆ Balance Sheet (โน Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 36 | 35 | 36 | 36 |
| Reserves | 281 | 258 | 356 | 324 |
| Borrowings | 284 | 267 | 311 | 307 |
| Total Liabilities | 779 | 734 | 897 | 843 |
| Fixed Assets | 265 | 201 | 312 | 255 |
| Investments | 3 | 3 | 3 | 3 |
| Total Assets | 779 | 734 | 897 | 843 |
The balance sheet shows stable equity levels with reserves growing from โน281 crore to โน356 crore over two years, indicating retained earnings are being accumulated. Borrowings have increased slightly from โน284 crore to โน311 crore, but remain manageable relative to equity and asset base. Total assets have risen steadily, reflecting capital investment or working capital growth, while the equity base remains resilient, suggesting no aggressive deleveraging or capital return initiatives are underway.
๐ฐ Cash Flow Statement (โน Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +35 |
| Investing | -82 |
| Financing | +42 |
| Net Cash Flow | -5 |
๐ฅ Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 58.4% | 58.4% | 58.4% | 58.4% |
| FII | 0.0% | 0.0% | 0.0% | 0.1% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% |
| Public | 26.6% | 26.6% | 26.4% | 26.5% |
| # Shareholders | 35,591 | 34,675 | 33,816 | 34,114 |
Promoter holding remains steady at 58.42% across all recent quarters, indicating no dilution or stake sales. Institutional ownership (FII/DII) is minimal, with FII at just 0.08% in Q1 FY27 and DII at 0%, suggesting limited foreign or domestic institutional interest. The broad retail shareholder base (34,114 shareholders) reflects widespread ownership but limited investor concentration. There are no signs of activist activity or significant shifts in investor sentiment through shareholding patterns.
โ๏ธ Peer Comparison โ Chemicals
| Company | MCap (โน Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | โ | 0.01 |
| SRF | 72,171 | 33.4 | 15.6% | โ | 0.36 |
| LINDEINDIA | 52,799 | 96.6 | 17.5% | โ | 0.00 |
| FLUOROCHEM | 48,503 | 79.3 | 9.6% | โ | 0.34 |
| NAVINFLUOR | 42,232 | 53.4 | 22.2% | โ | 0.31 |
| GODREJIND | 35,513 | 30.2 | 9.2% | โ | 4.57 |
| HSCL | 33,663 | 41.8 | 20.7% | โ | 0.16 |
| AETHER | 23,246 | 98.6 | 13.8% | โ | 0.08 |
| DEEPAKNTR | 20,783 | 26.5 | 15.3% | โ | 0.26 |
| CASTROLIND | 19,792 | 18.6 | 76.2% | โ | 0.00 |
๐ Peer Stock Analyses
โ ๏ธ Risk Factors
1. Margin pressure persists despite revenue growth, with OPM flattening at 12.4% in Q2 FY27, raising concerns about cost control in a competitive chemical market. 2. Low institutional interest may limit liquidity and analyst coverage, potentially leading to valuation volatility. 3. Heavy reliance on promoter group for governance control (58.42%) could constrain independent oversight if not balanced by robust board practices. 4. Flat revenue growth in recent quarters, despite capacity, may signal demand saturation or pricing headwinds in core segments.
๐ Recent Filings
- ๐ก Board Meeting2026-09-24Indo Amines held its 33rd AGM on September 24, 2026, approving a 10% final dividend ([amount context mismatch] per share), reappointing two directors,โฆ
- ๐ด Corporate Action2026-09-02Indo Amines announced a record date of September 17, 2026 for final dividend entitlement and 33rd AGM, with book closure from September 17 to 24, 2026โฆ
- ๐ด annual report2026-09-02Indo Amines Ltd (INDOAMIN) reported FY 2025-26 revenue of **โน1,15,966.09 lakhs** (up from โน1,07,867.86 lakhs), with profit before tax rising to **โน10,โฆ
- ๐ก Board Meeting2026-09-02Indo Amines Ltd announced its 33rd AGM on 24 September 2026, scheduled via video conferencing. Shareholders will vote on adopting FY 2025-26 financialโฆ
- Announcement2026-08-17Indo Amines Limited disclosed a gas leak incident at its Mahad manufacturing facility on August 15, 2026, resulting in two fatalities and temporary suโฆ
- Announcement2026-08-12Indo Amines Limited announced that the Gujarat Pollution Control Board revoked closure directions for its Vadodara plant effective August 11, 2026, alโฆ
- ๐ก Board Meeting2026-08-12Indo Amines Limited announced the outcome of its board meeting held on August 12, 2026, where it approved unaudited standalone and consolidated financโฆ
- Announcement2026-07-21Indo Amines Limited disclosed receipt of closure directions from Gujarat Pollution Control Board requiring shutdown of manufacturing at three Gujarat โฆ
- ๐ก voting results2026-07-17Indo Amines Limited announced that all four special resolutions proposed in its postal ballot notice dated May 26, 2026 were passed by shareholders viโฆ
- ๐ก Board Meeting2026-07-11Indo Amines appointed Rahul Chitnis as an Additional Independent Director for one year effective 15 July 2026, pending shareholder approval, as per SEโฆ
๐ง Analyst's Read
Indo Amines remains a profitable, low-debt chemical player with stable governance, but its near-term outlook hinges on margin recovery and top-line acceleration. Investors should monitor volume trends, input cost dynamics, and any shift in capital allocation strategy in upcoming quarters.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights โ sign up free to unlock.
Sign Up Free โ Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only โ not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when INDOAMIN files new disclosures
Track INDOAMIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track INDOAMIN โ FreeFree account ยท 2 AI queries/day